DCST2

Model summary

An ER-resident, multi-pass membrane scaffold that assembles ubiquitin-signaling modules to dampen interferon-driven innate immune pathways. Its DCST-like transmembrane core anchors the complex in the endoplasmic reticulum, while a C-terminal interaction domain recruits cytosolic partners to promote ubiquitin-dependent turnover and attenuation of signaling components. By organizing these assemblies at the ER interface, it negatively regulates innate immune and type I interferon signaling and contributes to ubiquitin-mediated protein catabolism.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The polypeptide is encompassed by IPR051856 (Cell Surface Receptor and E3 Ligase Protein family, residues 4–658), indicating a receptor-like scaffold that often couples extracellular/lumenal sensing to intracellular ubiquitin signaling. Within this framework sits IPR012858 (Dendritic cell-specific transmembrane protein-like domain, residues 354–544), a hallmark DCST/DCTP-like module that forms a multi-pass membrane core frequently used to organize endoplasmic reticulum (ER) quality-control assemblies. At the extreme C-terminus lies IPR058842 (E3 ubiquitin-protein ligase DCST1-like, C-terminal domain, residues 598–644), a DCST1-like tail that typically mediates cytosolic protein–protein interactions and recruitment of ubiquitin machinery. The ordered layout—broad receptor/E3-ligase family signature across the full length, a central DCST transmembrane module, and a C-terminal DCST1-like interaction domain—causes a membrane-embedded scaffold specialized for ubiquitin-coupled regulation rather than soluble catalysis.

2. 02

   This architecture dictates the molecular function as multivalent protein binding (GO:0005515).

   The DCST transmembrane core provides a stable membrane anchor and oligomerization platform, while the DCST1-like C-terminus supplies a cytosolic docking surface. Together they create a high-avidity assembly hub that binds substrates and adaptors without necessarily harboring a canonical catalytic center itself.

3. 03

   From this binding-centric mechanism, the biological processes follow.

   By recruiting and positioning ubiquitin-dependent modules at the ER, the complex promotes ubiquitin-dependent protein catabolic process (GO:0006511). In immune signaling, this scaffolded ubiquitin pathway attenuates type I interferon signaling; thus it enacts negative regulation of innate immune response (GO:0045824) and specifically negative regulation of type I interferon-mediated signaling pathway (GO:0060339). Mechanistically, ER-localized ubiquitin assembly can down-tune interferon outputs by routing pathway components toward degradation or functional silencing.

4. 04

   The cellular context is resolved by the membrane-centric domains and the experimentally supported location: a multi-pass ER resident that fits the endoplasmic reticulum membrane (GO:0005789).

   The DCST transmembrane block and overall receptor-like family signature enforce an integral membrane lifestyle, consistent with a multi-pass topology that situates cytosolic interaction modules distal to ER-resident lumenal loops.

5. 05

   Putting these elements together suggests a mechanism: an ER-embedded, DCST-like receptor/scaffold that nucleates ubiquitin machinery at the cytosolic face of the ER to restrain interferon signaling.

   It likely binds and organizes interferon-pathway adaptors and E3/E2 modules, steering them toward ubiquitin tagging and turnover. I hypothesize transient assemblies with interferon-axis regulators (e.g., STAT1/STAT2/IRF9 complexes), ER-associated degradation factors (SEL1L, HRD1/SYVN1), and cytosolic ubiquitin-conjugation systems (Cullin–RING ligases and UBE2 enzymes). These interactions would allow the ER-localized platform to dampen innate immune signaling by coupling substrate selection to ubiquitin-driven attenuation.